Molecular Diagnostic For Infectious Diseases Market Scope And Analysis

  • Report Code : TIPRE00030044
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 331
Buy Now

Molecular Diagnostic for Infectious Diseases Market Analysis 2031

Buy Now

Molecular Diagnostic for Infectious Diseases Market Report Molecular Diagnostic for Infectious Diseases Market Size and Share Molecular Diagnostic for Infectious Diseases Market Scope and Analysis

Molecular Diagnostic for Infectious Diseases Market Report Scope

Report Attribute Details
Market size in 2022 US$ 6.88 Billion
Market Size by 2030 US$ 17.61 Billion
Global CAGR (2022 - 2030) 12.5%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By Type
  • Point-of-Care Testing
  • Laboratory Testing
By End User
  • Point-of-Care Testing
  • Laboratory Testing
By Application
  • Point-of-Care Testing
  • Laboratory Testing
By Disease Type
  • Point-of-Care Testing
  • Laboratory Testing
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • F Hoffmann La Roche Ltd
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • bioMerieux SA
  • Danaher Corp
  • Hologic Inc
  • Siemens Healthineers AG
  • Bruker Corp
  • Molzym GmbH Co KG
  • DiaSorin SpA
    		•